Home | About Jay Hochman -Pediatric Gastroenterology Blog | Archives
August 26, 2014 7:00 am
From a recent JAMA Peds editorial: (JAMA Pediatr. Published online August 18, 2014. doi:10.1001/jamapediatrics.2014.1263)
An excerpt:
Gastroesophageal reflux disease (GERD) is common in infants and children and has been estimated to affect as much as 3.3% of the pediatric population.1 Despite this, we still struggle with the management of GERD. With a growing body of literature that illustrates a lack of efficacy and alarming adverse effects, there is increasing reason to limit the empirical use of acid suppression therapy in children.
Other points highlighted in this editorial:
Take-home message: “It is becoming clearer that in many circumstances, prescribing acid-reducing medication to infants is doing no good and increasing the risk of harm.”
Related blog posts:
Posted by gutsandgrowth
Categories: Pediatric Gastroenterology Intestinal Disorder
Tags: Gastroesophageal Reflux, GERD, infant
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.
[…] GERD Treatment in Infants: “Friend or Foe” | gutsandgrowth […]
By No Effect of Proton Pump Inhibitors and Irritability on Crying in Infants | gutsandgrowth on April 14, 2015 at 7:01 am
[…] GERD Treatment in Infants: “Friend or Foe” | gutsandgrowth […]
By The Prosecution Rests…PPIs on Trial | gutsandgrowth on January 12, 2016 at 7:00 am
[…] GERD Treatment in Infants: “Friend or Foe” | gutsandgrowth […]
By Two for the PPI Team | gutsandgrowth on May 9, 2017 at 7:01 am